Hawley urges DOJ probe into abortion pill maker over safety concerns Senator Josh Hawley is urging the Department of Justice to investigate Danco Laboratories, the producer of the abortion drug mifepristone, due to alleged undisclosed safety risks and potentially deceptive marketing practices. Hawley points to a study indicating a high rate of adverse events associated with the drug and criticizes Danco’s opaque corporate structure, including its incorporation in the Cayman Islands and secret investors. He requests a comprehensive investigation into the company’s FDA approval, regulatory compliance, manufacturing, distribution, and marketing.

• Sen. Josh Hawley has asked the Department of Justice to investigate Danco Laboratories, the manufacturer of mifepristone.
• Hawley alleges that “women are being harmed by this chemical abortion drug at far higher rates than advertised.”
• He criticizes Danco Laboratories for its secrecy, noting its incorporation in the Cayman Islands and hidden board of directors and investors.
• A study cited by Hawley suggests that 10.93% of women experience serious adverse events within 45 days of a mifepristone abortion.
• The FDA website notes serious adverse events and 36 reported deaths associated with mifepristone since its approval in 2000.
• Hawley’s subcommittee has also opened an investigation into Danco Laboratories.